Dividing patients into three groups, obstructive RAS (≥ 60% stenosis), non-obstructive RAS (10–60% stenosis) and normal renal arteries, we found no difference in Cyr61 levels in a population with high rates of diabetes mellitus, hypertension and obstructive coronary artery disease. This evidence concerns the gene CCN1 and coronary artery disorder.